Abstract
Background
Congenital cataract is of particular interest because of the variability of etiologies and the inflammatory reaction that are often observed. The aim of the study was to describe intraocular levels of various inflammation-related cytokines of patients with congenital cataract and to study their correlations with clinical determinants.
Methods
We followed a cohort of 18 patients (18 eyes) with congenital cataract from a University hospital and measured levels of various inflammation-related cytokines in the aqueous humor of patients with congenital cataract, and compared these levels to those observed in a control group (patients with senile cataract) using multiplex immunoassay. Correlation analysis was used to study the possible correlation between intraocular levels of cytokines and clinical determinants.
Results
Compared with the control group, the group with congenital cataract showed clear and significantly elevated concentrations of inflammatory markers (IL-1β, IL-15, IFN-γ, IL-12, IL-6, IL-5, IL-9, MIP-1α, MCP-1 and IP-10). Postoperative intraocular inflammation and opacification of the posterior capsule seemed to be correlated with preoperative IL-1β, TNF-α and IL-6 levels.
Conclusions
An inflammatory condition may occur in eyes with congenital cataract. The cytokine profiles are really different than those observed in senile cataract. Moreover, cytokines levels may be of interest to predict posterior capsule opacification and to complete the etiological workup.
Similar content being viewed by others
References
Foster A, Gilbert C, Rahi J (1997) Epidemiology of cataract in childhood: a global perspective. J Cataract Refract Surg 23(Suppl 1):601–604
Rahi JS, Dezateux C (2001) Measuring and interpreting the incidence of congenital ocular anomalies: lessons from a national study of congenital cataract in the UK. Invest Ophthalmol Vis Sci 42(7):1444–1448
Chan WH, Biswas S, Ashworth JL, Lloyd IC (2012) Congenital and infantile cataract: aetiology and management. Eur J Pediatr 171(4):625–630. doi:10.1007/s00431-012-1700-1
Zetterstrom C, Lundvall A, Kugelberg M (2005) Cataracts in children. J Cataract Refract Surg 31(4):824–840. doi:10.1016/j.jcrs.2005.01.012
Sukhija J, Kaur S, Ram J (2014) Minimizing inflammation after congenital cataract surgery. J Cataract Refract Surg 40(6):1056–1057. doi:10.1016/j.jcrs.2014.04.017
Ventura MC, Ventura BV, Ventura CV, Ventura LO, Arantes TE, Nose W (2014) Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone. J Cataract Refract Surg 40(4):601–608. doi:10.1016/j.jcrs.2013.09.011
BenEzra D, Cohen E (1997) Posterior capsulectomy in pediatric cataract surgery: the necessity of a choice. Ophthalmology 104(12):2168–2174
Vasavada AR, Praveen MR, Tassignon MJ, Shah SK, Vasavada VA, Van Looveren J, De Veuster I, Trivedi RH (2011) Posterior capsule management in congenital cataract surgery. J Cataract Refract Surg 37(1):173–193. doi:10.1016/j.jcrs.2010.10.036
Kuhli-Hattenbach C, Luchtenberg M, Kohnen T, Hattenbach LO (2008) Risk factors for complications after congenital cataract surgery without intraocular lens implantation in the first 18 months of life. Am J Ophthalmol 146(1):1–7. doi:10.1016/j.ajo.2008.02.014
Sauer A, Pfaff AW, Villard O, Creuzot-Garcher C, Dalle F, Chiquet C, Pelloux H, Speeg-Schatz C, Gaucher D, Prevost G, Bourcier T, Candolfi E (2012) Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis. J Infect Dis 206(8):1319–1329. doi:10.1093/infdis/jis486
Banasiak P, Strzalka-Mrozik B, Forminska-Kapuscik M, Filipek E, Mazurek U, Nawrocka L, Pieczara E, Berezowski P, Kimsa M (2011) Quantitative relationships between transforming growth factor beta mRNA isoforms in congenital and traumatic cataracts. Mol Vis 17:3025–33
Xiao Y, Zhao B, Gao Z, Pan Q (2009) Overaccumulation of transforming growth factor-beta1 and basic fibroblast growth factor in lens epithelial cells of congenital cataract. Can J Ophthalmol 44(2):189–92. doi:10.3129/i09-006
Chang KC, Petrash JM (2015) Aldose reductase mediates transforming growth factor β2 (TGF-β2)-induced migration and epithelial-to-mesenchymal transition of lens-derived epithelial cells. Invest Ophthalmol Vis Sci 56(8):4198–210. doi:10.1167/iovs.15-16557
Sauer A, Villard O, Creuzot-Garcher C, Chiquet C, Berrod JP, Speeg-Schatz C, Bourcier T, Candolfi E (2015) Intraocular levels of interleukin 17A (IL-17A) and IL-10 as respective determinant markers of toxoplasmosis and viral uveitis. Clin Vaccine Immunol 22(1):72–78. doi:10.1128/CVI.00423-14
Lahmar I, Abou-Bacar A, Abdelrahman T, Guinard M, Babba H, Ben Yahia S, Kairallah M, Speeg-Schatz C, Bourcier T, Sauer A, Villard O, Pfaff AW, Mousli M, Garweg JG, Candolfi E (2009) Cytokine profiles in toxoplasmic and viral uveitis. J Infect Dis 199(8):1239–1249. doi:10.1086/597478
Apple DJ, Ram J, Foster A, Peng Q (2000) Elimination of cataract blindness: a global perspective entering the new millenium. Surv Ophthalmol 45(Suppl 1):S1–196
Levi DM, Knill DC, Bavelier D (2015) Stereopsis and amblyopia: a mini-review. Vis Res. doi:10.1016/j.visres.2015.01.002
Pechereau A, Paire V, Raffin L, Tessier H, Lebranchu P (2011) Amblyopia treatment of unilateral and bilateral cataract with visual acuity result. J Fr Ophtalmol 34(3):208–212. doi:10.1016/j.jfo.2011.01.009
Plager DA, Lynn MJ, Buckley EG, Wilson ME, Lambert SR (2011) Complications, adverse events, and additional intraocular surgery 1 year after cataract surgery in the infant Aphakia Treatment Study. Ophthalmology 118(12):2330–2334. doi:10.1016/j.ophtha.2011.06.017
Plager DA, Lynn MJ, Buckley EG, Wilson ME, Lambert SR (2014) Complications in the first 5 years following cataract surgery in infants with and without intraocular lens implantation in the Infant Aphakia Treatment Study. Am J Ophthalmol. doi:10.1016/j.ajo.2014.07.031
Mochizuki M, Sugita S, Kamoi K (2013) Immunological homeostasis of the eye. Prog Retin Eye Res 33:10–27. doi:10.1016/j.preteyeres.2012.10.002
Caspi R (2008) Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol Res 42(1–3):41–50. doi:10.1007/s12026-008-8031-3
Bi HS, Liu ZF, Cui Y (2015) Pathogenesis of innate immunity and adaptive immunity in the mouse model of experimental autoimmune uveitis. J Chin Med Assoc 78(5):276–282. doi:10.1016/j.jcma.2015.01.002
Forrester JV, Xu H, Kuffova L, Dick AD, McMenamin PG (2010) Dendritic cell physiology and function in the eye. Immunol Rev 234(1):282–304. doi:10.1111/j.0105-2896.2009.00873.x
Jones CV, Ricardo SD (2013) Macrophages and CSF-1: implications for development and beyond. Organogenesis 9(4):249–260. doi:10.4161/org.25676
Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8(9):1254–1266. doi:10.7150/ijbs.4679
Kared H, Camous X, Larbi A (2014) T cells and their cytokines in persistent stimulation of the immune system. Curr Opin Immunol 29:79–85. doi:10.1016/j.coi.2014.05.003
Croce M, Orengo AM, Azzarone B, Ferrini S (2012) Immunotherapeutic applications of IL-15. Immunotherapy 4(9):957–969. doi:10.2217/imt.12.92
Sharma N, Pushker N, Dada T, Vajpayee RB, Dada VK (1999) Complications of pediatric cataract surgery and intraocular lens implantation. J Cataract Refract Surg 25(12):1585–1588
Shah SK, Vasavada V, Praveen MR, Vasavada AR, Trivedi RH, Dixit NV (2009) Triamcinolone-assisted vitrectomy in pediatric cataract surgery. J Cataract Refract Surg 35(2):230–232. doi:10.1016/j.jcrs.2008.10.037
van Tenten Y, Schuitmaker HJ, De Groot V, Willekens B, Vrensen GF, Tassignon MJ (2002) A preliminary study on the prevention of posterior capsule opacification by photodynamic therapy with bacteriochlorin A in rabbits. Ophthalmic Res 34(3):113–118
Panahi-Bazaz MR, Zamani M, Abazar B (2009) Hydrophilic acrylic versus PMMA intraocular lens implantation in pediatric cataract surgery. J Ophthalmic Vis Res 4(4):201–207
Ram J, Brar GS, Kaushik S, Sukhija J, Bandyopadhyay S, Gupta A (2007) Primary intraocular lens implantation in the first two years of life: safety profile and visual results. Indian J Ophthalmol 55(3):185–189
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was done with governmental grants, “PHRC (Protocole Hospitalier de Recherche Clinique) 3964: Infections intraoculaires graves”. The sponsor had no role in the design or conduct of this research.
Conflict of interest
All authors certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Table 4
Means and standard deviations of cytokines and chemokines concentrations (pg/mL) in aqueous humor for right and left eyes in patients with bilateral congenital cataracts. (DOC 46 kb)
Rights and permissions
About this article
Cite this article
Sauer, A., Bourcier, T., Gaucher, D. et al. Intraocular cytokines imbalance in congenital cataract and its impact on posterior capsule opacification. Graefes Arch Clin Exp Ophthalmol 254, 1013–1018 (2016). https://doi.org/10.1007/s00417-016-3313-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3313-2